The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance
Open Access
- 29 May 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 787
- https://doi.org/10.3389/fphar.2020.00787
Abstract
Autophagy is a mechanism involved in many human diseases and in cancers can have a cytotoxic/cytostatic or protective action, being in the latter case involved in multidrug resistance. Understanding which of these roles autophagy has in cancer is thus fundamental for therapeutical decisions because it permits to optimize the therapeutical approach by activating or inhibiting autophagy according to the progression of the disease. However, a serious drawback of cancer treatment is often the scarce availability of drugs and autophagy modulators at the sites of interest. In the recent years, several nanocarriers have been developed and investigated to improve the solubility, bioavailability, controlled release of therapeutics and increase their cytotoxic effect on cancer cell. Here we have reviewed only liposomes as carriers of chemotherapeutics and autophagy inhibitors because they have low toxicity and immunogenicity and they are biodegradable and versatile. In this review after the analysis of the dual role of autophagy, of the main autophagic pathways, and of the role of autophagy in multidrug resistance, we will focus on the most effective liposomal formulations, thus highlighting the great potential of these targeting systems to defeat cancer diseases.This publication has 129 references indexed in Scilit:
- Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in VivoACS Nano, 2012
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cellsCell Death & Disease, 2012
- Autophagy-deficient mice develop multiple liver tumorsGenes & Development, 2011
- Principles and Current Strategies for Targeting Autophagy for Cancer TreatmentClinical Cancer Research, 2011
- Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST)Proceedings of the National Academy of Sciences of the United States of America, 2010
- FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end–directed vesicle transportThe Journal of cell biology, 2010
- The Tor and PKA signaling pathways independently target the Atg1/Atg13 protein kinase complex to control autophagyProceedings of the National Academy of Sciences of the United States of America, 2009
- Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transportersBiopharmaceutics & Drug Disposition, 2009
- Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 DomainsMolecular and Cellular Biology, 2009
- The structure of Atg4B–LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagyThe EMBO Journal, 2009